PTC Therapeutics, Inc. - Common Stock (NQ:PTCT)

71.70 -1.87 (-2.54%)

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 16, 2026 Add to My Watchlist

Price and Volume

Volume	1,171,065
Open	72.98
Bid (Size)	66.20 (100)
Ask (Size)	114.64 (200)
Prev. Close	73.57
Today's Range	70.89 - 73.53
52wk Range	35.95 - 87.50
Shares Outstanding	81,474,366
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

This New $193 Million Bet Targets a Biotech With $689 Million in Revenue and a Potential Turnaround Story ↗

March 21, 2026

This biotech firm develops therapies for rare, complement-driven diseases, with a focus on autoimmune and inflammatory conditions.

Via The Motley Fool

This $116 Million Buy Joins a 360% Stock Run and Seemingly Signals Conviction in a Key Drug Launch ↗

March 21, 2026

Cogent Biosciences develops targeted therapies for genetically defined diseases, focusing on precision medicine for rare cancers.

Via The Motley Fool

Performance

YTD	-6.6%	-6.6%
1 Month	+7.5%	+7.5%
3 Month	-7.2%	-7.2%
6 Month	+4.7%	+4.7%
1 Year	+52.7%	+52.7%

More News

This Specialized Heart Monitor Maker Just Caught the Eye of a Major Healthcare Fund ↗

March 20, 2026

Via The Motley Fool

PTC Therapeutics Inc (NASDAQ:PTCT) Stock Slides After Q4 Earnings Miss ↗

February 19, 2026

Via Chartmill

PTC Therapeutics Inc (NASDAQ:PTCT) Presents a Compelling Growth and Technical Setup ↗

February 12, 2026

Via Chartmill

PTC Therapeutics Inc (NASDAQ:PTCT): A GARP Stock with Strong Growth and Moderate Valuation ↗

February 07, 2026

Via Chartmill

Investment Manager Bets Big on PTCT Stock, Adds 41,000 Shares, According to Recent SEC Filing ↗

March 03, 2026

Via The Motley Fool

Investment Firm Adds Nearly $4 Milllion Worth of DYN Shares, According to Recent SEC Filing ↗

March 02, 2026

Via The Motley Fool

Investment Advisor Bets Big on CMPX Stock, Adds 2.5 Million Shares, According to Latest SEC Filing ↗

March 02, 2026

Via The Motley Fool

PTC Therapeutics Inc (NASDAQ:PTCT) Combines High-Growth Momentum with Bullish Technical Setup ↗

February 02, 2026

Via Chartmill

PTC Therapeutics Inc (NASDAQ:PTCT) Emerges as a High-Growth Momentum Breakout Candidate ↗

January 12, 2026

Via Chartmill

PTC Therapeutics Inc (NASDAQ:PTCT) Combines Strong Growth with a Bullish Technical Setup ↗

January 09, 2026

Via Chartmill

PTC Therapeutics Inc (NASDAQ:PTCT): A Prime Candidate for Affordable Growth Investing ↗

January 01, 2026

Via Chartmill

PTC THERAPEUTICS INC (NASDAQ:PTCT) Shows High-Growth Momentum and Bullish Technical Setup ↗

December 15, 2025

Via Chartmill

PTC Therapeutics Inc (NASDAQ:PTCT) Presents a Compelling Growth and Technical Setup ↗

December 13, 2025

Via Chartmill

PTC Therapeutics Inc (NASDAQ:PTCT): A GARP Stock with Strong Growth and Reasonable Valuation ↗

December 10, 2025

Via Chartmill

Healthcare Investor Exits $13 Million Stake STAAR Surgical Stake as Alcon Deal Drama Looms ↗

December 03, 2025

Via The Motley Fool

Rare-Disease Biotech PTC Is Surging — And One Fund Just Raised Its Bet. Should You? ↗

December 02, 2025

Via The Motley Fool

PTC Therapeutics Swings to a Profit on $211 Million in Revenue — Is This Why a Major Fund Just Invested $32 Million? ↗

December 03, 2025

Via The Motley Fool

Dyne Therapeutics Stock Down 30% in a Year — So Why Did One Investor Add Nearly 1 Million Shares? ↗

December 03, 2025

Via The Motley Fool

Capricor Therapeutics (NASDAQ: CAPR) Soars 535% to Eight-Year High on Landmark Duchenne Muscular Dystrophy Treatment Results

December 03, 2025

Via MarketMinute

Aurinia Raises Guidance and Shares Are Surging— Is This Why a Major Investor Just Boosted Its Stake? ↗

December 02, 2025

Via The Motley Fool

A PTC Therapeutics (PTCT) Insider Sold 10,000 Shares for $795,000 ↗

November 29, 2025

Via The Motley Fool

PTC THERAPEUTICS INC (NASDAQ:PTCT) Presents an Affordable Growth Opportunity ↗

November 19, 2025

Via Chartmill

This Fund Sold $30 Million in PTC Therapeutics Shares Amid a 93% Rally: Here’s Why ↗

November 18, 2025

Via The Motley Fool

Frequently Asked Questions

Is PTC Therapeutics, Inc. - Common Stock publicly traded?

Yes, PTC Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does PTC Therapeutics, Inc. - Common Stock trade on?

PTC Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for PTC Therapeutics, Inc. - Common Stock?

The ticker symbol for PTC Therapeutics, Inc. - Common Stock is PTCT on the Nasdaq Stock Market

What is the current price of PTC Therapeutics, Inc. - Common Stock?

The current price of PTC Therapeutics, Inc. - Common Stock is 71.70

When was PTC Therapeutics, Inc. - Common Stock last traded?

The last trade of PTC Therapeutics, Inc. - Common Stock was at 04/16/26 04:00 PM ET

What is the market capitalization of PTC Therapeutics, Inc. - Common Stock?

The market capitalization of PTC Therapeutics, Inc. - Common Stock is 5.84B

How many shares of PTC Therapeutics, Inc. - Common Stock are outstanding?

PTC Therapeutics, Inc. - Common Stock has 6B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.